ارزیابی آپوپتوز القاء شده توسط ویروس بیماری نیوکاسل سویه لاسوتا در سلول‌های سرطانی پستان انسان

Adams, W.R., Prince, A.F., 1959. Cellular changes associated with infection of the Ehrlich ascites tumor with Newcastle disease virus. A NY Acad Sci 81, 89-100.

Alexander, D.J., 2000. Newcastle disease and other avian paramyxoviruses. Rev Sci Tech 19, 443-462.

Bouchet, B.P., Caron de Fromentel, C., Puisieux, A., Galmarini, C.M., 2006. p53 as a target for anti-cancer drug development. Crit Rev Oncol Hematol 58, 190-207.

Cantin, C., Holguera, J., Ferreira, L., Villar, E., Munoz-Barroso, I., 2007. Newcastle disease virus may enter cells by caveolae-mediated endocytosis. J Gen Virol 88, 559-569.

Chiocca, E.A., Rabkin, S.D., 2014. Oncolytic viruses and their application to cancer immunotherapy. Cancer Immunol Res 2, 295-300.

Chittenden, T., Flemington, C., Houghton, A.B., Ebb, R.G., Gallo, G.J., Elangovan, B., et al., 1995. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J 14, 5589-5596.

Csatary, L., 1971. Viruses in the Treatment of Cancer. Lancet 298, 825.

Danial, N.N., Korsmeyer, S.J., 2004. Cell Death: Critical Control Points. Cell 116, 205-219.

Degenhardt, K., Sundararajan, R., Lindsten, T., Thompson, C., White, E., 2002. Bax and Bak independently promote cytochrome C release from mitochondria. J Biol Chem 277, 14127-14134.

Elankumaran, S., Rockemann, D., Samal, S.K., 2006. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J Virol 80, 7522-7534.

Elmore, S., 2007. Apoptosis: a review of programmed cell death. Toxicol Pathol 35, 495-516.

Fabian, Z., Csatary, C.M., Szeberenyi, J., Csatary, L.K., 2007. p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines. J Virol 81, 2817-2830.

Farashi-Bonab, S., Khansari, N., 2017a. Virotherapy with Newcastle Disease Virus for Cancer Treatment and its Efficacy in Clinical Trials. MOJ Immunol 5, 00176.

Farashi-Bonab, S., Khansari, N., 2017b. Immunobiology of anticancer virotherapy with Newcastle disease virus in cancer patients. Vaccin Res Open J 1, 45-53.

Fiola, C., Peeters, B., Fournier, P., Arnold, A., Bucur, M., Schirrmacher, V., 2006. Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defence. Int J Cancer 119, 328-338.

Gerl, R., Vaux, D.L., 2005. Apoptosis in the development and treatment of cancer. Carcinogenesis 26, 263-270.

Ghrici, M., El Zowalaty, M., Omar, A.R., Ideris, A., 2013a. Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240. Oncol Rep 30, 1035-1044.

Ghrici, M., El Zowalaty, M., Omar, A.R., Ideris, A., 2013b. Newcastle disease virus Malaysian strain AF2240 induces apoptosis in MCF-7 human breast carcinoma cells at an early stage of the virus life cycle. Int J Mol Med 31, 525-532.

Ilkow, C.S., Swift, S.L., Bell, J.C., Diallo, J.S., 2014. From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer. PLoS Pathog 10, e1003836.

Kaufman, H.L., Kohlhapp, F.J., Zloza, A., 2016. Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov 14, 642-662.

Kelly, E., Russell, S.J., 2007. History of oncolytic viruses: genesis to genetic engineering. Mol Ther 15, 651-659.

Kumar, R., Tiwari, A.K., Chaturvedi, U., Kumar, G.R., Sahoo, A.P., Rajmani, R.S., et al., 2012. Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization. Appl Biochem Biotechnol 167, 2005-2022.

Lam, K.M., Vasconcelos, A.C., Bickford, A.A., 1995. Apoptosis as a cause of death in chicken embryos inoculated with Newcastle disease virus. Microb Pathog 19, 169-174.

Lang, F.F., Conrad, C., Gomez-Manzano, C., Yung, W.K.A., Sawaya, R., Weinberg, J.S., et al., 2018. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. J Clin Oncol 36, 1419-1427.

Molouki, A., Hsu, Y.T., Jahanshiri, F., Rosli, R., Yusoff, K., 2010. Newcastle disease virus infection promotes Bax redistribution to mitochondria and cell death in HeLa cells. Intervirology 53, 87-94.

Molouki, A., Yusoff, K., 2012. NDV-induced apoptosis in absence of Bax; evidence of involvement of apoptotic proteins upstream of mitochondria. Virol J 9, 179.

Moore, A.E., Diamond, L.C., Mackay, H.H., Sabachewsky, L., 1952. Influence of hemagglutinating viruses on tumor cell suspensions. II. Newcastle disease virus and Ehrlich carcinoma. Proceedings of the Society for Experimental Biology and Medicine. Soc Exp Biol Med 81, 498-501.

Msaouel, P., Opyrchal, M., Dispenzieri, A., Peng, K.W., Federspiel, M.J., Russell, S.J., et al., 2018. Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects. Curr Cancer Drug Targets 18, 177-187.

Ozaki, T., Nakagawara, A., 2011. Role of p53 in Cell Death and Human Cancers. Cancers 3, 994-1013.

Prince, A.M., Ginsberg, H.S., 1957. Immunohistochemical studies on the interaction between Ehrlich ascites tumor cells and Newcastle disease virus. J Exp Med 105, 177-188.

Rajmani, R.S., Gandham, R.K., Gupta, S.K., Sahoo, A.P., Singh, P.K., Kumar, R., et al., 2015. HN Protein of Newcastle Disease Virus Induces Apoptosis Through SAPK/JNK Pathway. Appl Biochem Biotechnol 177, 940-956.

Ravindra, P.V., Tiwari, A.K., Ratta, B., Chaturvedi, U., Palia, S.K., Chauhan, R.S., 2009. Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis. Virus Res 141, 13-20.

Ravindra, P.V., Tiwari, A.K., Ratta, B., Chaturvedi, U., Palia, S.K., Subudhi, P.K., et al., 2008a. Induction of apoptosis in Vero cells by Newcastle disease virus requires viral replication, de-novo protein synthesis and caspase activation. Virus Res133, 285-290.

Ravindra, P.V., Tiwari, A.K., Sharma, B., Rajawat, Y.S., Ratta, B., Palia, S., et al., 2008b. HN protein of Newcastle disease virus causes apoptosis in chicken embryo fibroblast cells. Arch Virol 153, 749-754.

Ries, S.J., Brandts, C.H., 2004. Oncolytic viruses for the treatment of cancer: current strategies and clinical trials. Drug Discov Today 9, 759-768.

Russell, L., Peng, K.W., 2018. The emerging role of oncolytic virus therapy against cancer. Chin Clin Oncol 7, 16.

Santry, L.A., McAusland, T.M., Susta, L., Wood, G.A., Major, P.P., Petrik, J.J., et al., 2018. Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer. Mol Ther Methods Clin 9, 181-191.

Shamas-Din, A., Kale, J., Leber, B., Andrews, D.W., 2013. Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb Perspect Biol 5, a008714.

Shimizu, S., Narita, M., Tsujimoto, Y., 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487.

Wheelock, E.F., Dingle, J.H., 1964. Observations on the Repeated Administration of Viruses to a Patient with Acute Leukemia. A Preliminary Report. N Engl J Med 271, 645-651.

Wong, R.S., 2011. Apoptosis in cancer: from pathogenesis to treatment. Journal of experimental & clinical cancer research : CR 30, 87.

Zhivotovsky, B., Orrenius, S., 2006. Carcinogenesis and apoptosis: paradigms and paradoxes. Carcinogenesis 27, 1939-1945.